Clinical trials
Phase 3 Leukemia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 2 |
| 2005 | 2 |
| 2007 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 7 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 9 |
| Children's Oncology Group | 4 |
| Novartis Pharmaceuticals | 2 |
| Acerta Pharma BV | 1 |
| Ariad Pharmaceuticals | 1 |
| Celgene Corporation | 1 |
| Daiichi Sankyo | 1 |
| Dutch Childhood Oncology Group | 1 |
| Facet Biotech | 1 |
| Institut de Recherches Internationales Servier | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 26 |
| Leukemia, Myeloid, Acute | 9 |
| Myelodysplastic Syndromes | 6 |
| Leukemia, Erythroblastic, Acute | 4 |
| Leukemia, Megakaryoblastic, Acute | 4 |
| Leukemia, Monocytic, Acute | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Leukemia, Myelomonocytic, Acute | 4 |
| Myeloproliferative Disorders | 4 |
| Anemia, Refractory | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.